MTOR and diabetic encephalopathy: Xu et al. [30] found that inhibition of the mammalian target of rapamycin (mTOR)/nuclear factor kappa-B (NF-κB) signaling pathway in a mouse model of diabetic encephalopathy resulted in improved cognitive performance and elevated levels of SYN to regulate synaptic plasticity.